[Dialysis encephalopathy].
Kinugasa
Eriko
E
Department of Internal Medicine, Showa University Northern Yokohama Hospital.
Yamamoto
Masahiro
M
Fukui
Tosiya
T
D000535:Aluminum / Q000009:adverse effects* / Q000302:isolation & purification; D003676:Deferoxamine / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D003937:Diagnosis, Differential; D003956:Dialysis / Q000009:adverse effects*; D015314:Dialysis Solutions / Q000737:chemistry; D004340:Drug Contamination; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use; D011379:Prognosis
D015314:Dialysis Solutions; D007502:Iron Chelating Agents; D000535:Aluminum; D003676:Deferoxamine